Eliminating Hepatitis C

Presented by Apoorva Mallya, Executive Director of Hepatitis Education Project (HEP)
In the US, there are more than 3 million people infected with hepatitis C, a disease that has devastating impacts across the body and is a leading cause of liver cancer. Prevalence of hepatitis C is highest amongst people who currently use drugs or have in the past. At the same time, there is 98% effective cure available for hepatitis C that is simple to administer and has low side effects. With the development of this cure, the public health community has set its sights on elimination of hepatitis C, which would prevent cases and save lives for generations. However, reaching elimination would require a major increase in treatment, as less than 1/3rd of people diagnosed with hepatitis C have been treated. A broad group of providers and organizations, particularly those serving people who currently or formerly use drugs, will need to begin offering or expand hepatitis C services to their patients. In this session, you will learn more about hepatitis C and potential pathways to scale up hepatitis C services!